WS14.02 Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
Ciobanu, D., Liessi, N., Tomati, V., Dobi, D., Capurro, V., Loberto, N., Aureli, M., Pedemonte, N., Bassi, R., Armirotti, A.
Published in Journal of cystic fibrosis (01.06.2024)
Published in Journal of cystic fibrosis (01.06.2024)
Get full text
Journal Article
P004 Clinical consequences and functional impact of the rare S737F CFTR variant
Terlizzi, V., Pesce, E., Lena, M.T., Tomati, V., Capurro, V., Pastorino, C., Bocciardi, R., Centrone, C., Taccetti, G., Castellani, C., Pedemonte, N.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
351 Beyond elexacaftor/tezacaftor/ivacaftor: mechanistic insights to maximize N1303K-CFTR rescue
Pranke, I., Capurro, V., Chevalier, B., Pesce, E., Tomati, V., Pastorino, C., Hatton, A., Dreano, E., Kelly-Aubert, M., Guerrera, C., Galietta, L., Girodon, E., Burgel, P., Sermet-Gaudelus, I., Hinzpeter, A., Pedemonte, N.
Published in Journal of cystic fibrosis (01.09.2024)
Published in Journal of cystic fibrosis (01.09.2024)
Get full text
Journal Article
WS05.02 CFTR rescue by lumacaftor (VX-809) induces an extensive reorganisation of mitochondria in the cystic fibrosis bronchial epithelium
Armirotti, A., Braccia, C., Christopher, J., Crook, O., Breckels, L., Queiroz, R., Liessi, N., Tomati, V., Capurro, V., Bandiera, T., Baldassari, S., Pedemonte, N., Lilley, K.
Published in Journal of cystic fibrosis (01.06.2022)
Published in Journal of cystic fibrosis (01.06.2022)
Get full text
Journal Article